VivaLink Proudly Announces the Launch of a Multi Vital Monitoring Solution for Infectious Respiratory Diseases

VivaLink, a leading provider of connected healthcare solutions known for its unique medical wearable sensor platform, announces today the availability of its new multi vital ambulatory monitoring solution for Infectious Respiratory Diseases. Currently deployed in Asia, Eastern Europe and the Middle East, it is now available in the Americas and Western Europe.

“VivaLink’s continuous temperature monitor wearable, which was used for the first time in the fight against COVID-19 in our hospital, really reduced cross infection risks for our doctors and nurses due to its capabilities to provide data and vitals remotely. We used more than 200 temperature monitors throughout our hospital, and it made a huge impact in the care we were able to provide,” said Ms Zhang, deputy director of the nursing department of the Shanghai Public Health Clinical Center.

Built upon VivaLink’s proprietary ambulatory medical wearable sensor platform, the solution can easily be set up and scaled in hospitals, nursing homes and remote environments. Even pop-up hospitals with little to no network and IT infrastructure can be supported with the flexible platform. Once deployed, nurses and caregivers can effectively manage the vitals of all patients from a centralized console to easily identify changes, and view trends and history.

The multi vital monitoring solution includes:

  • Vitals: temperature, heart rate, respiratory rate, Sp02 Oxygen Saturation , and ECG
  • Reusable sensors with continuous monitoring and live streaming
  • Centralized patient monitoring application console
  • On-premise data server software
  • RPM option with patient companion app and cloud hosting
  • Up to 21 days of continuous monitoring on a single charge

“Continuous monitoring of patients’ vitals is essential for early detection of symptoms of infectious diseases, especially as we navigate the changing landscape of COVID-19,” said Jiang Li, Founder and CEO of VivaLNK. “With temperature, heart rate and Sp02, it rounds out the key vitals for infectious respiratory diseases monitoring.”

The VivaLNK solution works by automatically and continuously collecting patient vitals, and wirelessly sending it to a secure on-premise server via a Bluetooth Low Energy (BLE) WiFi router. The data is then consolidated and presented to a centralized console for caregivers. In RPM or remote field hospital deployments, an optional patient app and mobile device, and a cloud hosted application are available.

This solution is currently deployed in 15 hospitals (1,500 beds) in China for on premise in-patient monitoring of COVID-19, and in Romania, Qatar, and UAE using the mobile option.

 

SourceVivaLink

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.